Supplements & U

By:
Jordan Burr,
Jon Rahm-Rodriguez, and
Mac Castro

Whats up with supplements, yo?

Why?
Diverse
consumer
market (in
the U.S.)
Unregulated
Untested

What?

Demographics
Response Rate:
Participants: 44
Age Range: 16-67
Age Average: 23
Age Median: 26
Gender:
Academic Disciplines: 22 students (9 graduate), 22 non-students.
Race/Ethnicity:

Graphics

Questions asked:
1. Did you know no research must be done before
supplements are marketed? Would you support an
appeal to the FDA to change their regulation policies?
. Hypothesis:
People would be in favor of an FDA appeal on supplement
regulation and an increased demand for testing.

Question: 1 (a/b)
Question:
Summary :

Analysis: A large portion of the participants take

supplements for one reason or another.

Question: 2 (a/b)
Question:
Summary :

Analysis: Of those who take supplements, most take

vitamins. The majority of participants do not take any.

Question: 3 (a/b)
Question:
Summary :

Analysis: Most participants have heard of risks associated

with supplements.

Question: 4
Question:
Summary :

Analysis: 20% of participants knew someone affect by

supplements badly, 40% didnt know they were not
regulated.

Question: 5
Question:
Summary :

Analysis: The vast majority of participants are in favor of

both stronger FDA regulations and more mandatory
research.

Conclusion
After reviewing the literature
and collecting the data, we
conclude that the average
person takes supplements, is
aware the risks, and believes
that some sort of action should
be taken to strengthen the
regulations of them.

Recommendation
After reviewing the data, our team
recommends:
1. Widen the parameters of the study.
2. Individualized research on products
(academic).
3. FDA appeal to increase overall regulation
(legislative).

Questions

Gracias, danke, and eskerrik asko.

References
EURODIAB Substudy 2 Study Group. (1999). Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus.
Diabetologia, 42(1), 51-54.
Gunja, N., & Brown, J. A. (2012). Energy drinks: Health risks and toxicity. The Medical Journal of Australia, 196(1), 46-49. doi:gun10838_fm [pii]
Leitzmann, M. F., Stampfer, M. J., Wu, K., Colditz, G. A., Willett, W. C., & Giovannucci, E. L. (2003). Zinc supplement use and risk of prostate
cancer. Journal of the National Cancer Institute, 95(13), 1004-1007.
Losonczy, K. G., Harris, T. B., & Havlik, R. J. (1996). Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease
mortality in older persons: The established populations for epidemiologic studies of the elderly. The American Journal of Clinical Nutrition, 64(2),
190-196.
Rimm, E. B., Willett, W. C., Hu, F. B., Sampson, L., Colditz, G. A., Manson, J. E., . . . Stampfer, M. J. (1998). Folate and vitamin B6 from diet
and supplements in relation to risk of coronary heart disease among women. Jama, 279(5), 359-364.
Tepaske, R., te Velthuis, H., Oudemans-van Straaten, H. M., Heisterkamp, S. H., van Deventer, S. J., Ince, C., . . . Kesecioglu, J. (2001). Effect
of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: A randomised placebocontrolled trial. The Lancet, 358(9283), 696-701.